Sector Gamma As as of March 31, 2022
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 40 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merck & Co (MRK) | 8.9 | $41M | 499k | 82.05 | |
| Gilead Sciences (GILD) | 8.8 | $41M | 682k | 59.45 | |
| Incyte Corporation (INCY) | 7.6 | $35M | 442k | 79.42 | |
| Bristol Myers Squibb (BMY) | 5.3 | $24M | 334k | 73.03 | |
| Medtronic SHS (MDT) | 5.0 | $23M | 206k | 110.95 | |
| Cardinal Health (CAH) | 4.6 | $21M | 377k | 56.70 | |
| CVS Caremark Corporation (CVS) | 4.4 | $20M | 199k | 101.21 | |
| Boston Scientific Corporation (BSX) | 3.8 | $18M | 395k | 44.29 | |
| Biogen Idec (BIIB) | 3.8 | $17M | 82k | 210.60 | |
| Centene Corporation (CNC) | 3.6 | $16M | 195k | 84.19 | |
| Bruker Corporation (BRKR) | 3.5 | $16M | 252k | 64.30 | |
| NuVasive | 3.3 | $15M | 266k | 56.70 | |
| Anthem (ELV) | 3.1 | $14M | 29k | 491.21 | |
| Cigna Corp (CI) | 3.0 | $14M | 58k | 239.61 | |
| Organon & Co Common Stock (OGN) | 2.6 | $12M | 340k | 34.93 | |
| Qiagen Nv Shs New | 2.3 | $11M | 219k | 49.00 | |
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $9.7M | 59k | 163.29 | |
| Elanco Animal Health (ELAN) | 2.1 | $9.5M | 365k | 26.09 | |
| Zimmer Holdings (ZBH) | 1.8 | $8.3M | 65k | 127.90 | |
| Astrazeneca Sponsored Adr (AZN) | 1.8 | $8.2M | 124k | 66.34 | |
| Bio Rad Labs Cl A (BIO) | 1.6 | $7.2M | 13k | 563.24 | |
| Ionis Pharmaceuticals (IONS) | 1.5 | $7.0M | 188k | 37.04 | |
| Becton, Dickinson and (BDX) | 1.5 | $7.0M | 26k | 266.00 | |
| Universal Hlth Svcs CL B (UHS) | 1.5 | $6.9M | 48k | 144.94 | |
| Pfizer (PFE) | 1.5 | $6.7M | 130k | 51.77 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.4 | $6.5M | 25k | 260.97 | |
| BioMarin Pharmaceutical (BMRN) | 1.3 | $6.1M | 80k | 77.09 | |
| Intra Cellular Therapies (ITCI) | 1.1 | $4.9M | 81k | 61.19 | |
| Rigel Pharmaceuticals Com New (RIGL) | 1.0 | $4.4M | 1.5M | 2.99 | |
| Patterson Companies (PDCO) | 0.9 | $4.2M | 130k | 32.37 | |
| Sage Therapeutics (SAGE) | 0.9 | $3.9M | 119k | 33.10 | |
| Ultragenyx Pharmaceutical (RARE) | 0.7 | $3.4M | 46k | 72.63 | |
| Ptc Therapeutics I (PTCT) | 0.6 | $3.0M | 80k | 37.31 | |
| Novavax Com New (NVAX) | 0.6 | $2.8M | 38k | 73.66 | |
| Dentsply Sirona (XRAY) | 0.6 | $2.7M | 56k | 49.21 | |
| Quanterix Ord (QTRX) | 0.6 | $2.6M | 89k | 29.19 | |
| Somalogic Class A Com | 0.5 | $2.4M | 301k | 8.02 | |
| Vir Biotechnology (VIR) | 0.4 | $2.1M | 80k | 25.72 | |
| Atara Biotherapeutics (ATRA) | 0.2 | $1.1M | 124k | 9.29 | |
| Mirati Therapeutics | 0.2 | $976k | 12k | 82.19 |
